Previous studies demonstrated that FGF23 inhibited parathyroid hormone secretion through MAPK pathway [63] or induced myocardial hypertrophy mediated by activation of PLCγ-calcineurin-NFAT pathway [23]. Here, FGF23 is linked to cardiac hypertrophy.